Breaking News Instant updates and real-time market news.

AMGN

Amgen

$176.61

-0.22 (-0.12%)

13:03
06/14/19
06/14
13:03
06/14/19
13:03

Amgen acute myeloid leukemia treatment granted FDA orphan status

Amgen's treatment of acute myeloid leukemia was granted orphan designation by the FDA, according to a post to the agency's website. Reference Link

  • 16

    Sep

AMGN Amgen
$176.61

-0.22 (-0.12%)

06/04/19
RHCO
06/04/19
NO CHANGE
Target $120
RHCO
Buy
Mirati Therapeutics price target raised to $120 from $85 at SunTrust
SunTrust analyst Peter Lawson raised his price target on Mirati Therapeutics (MRTX) to $120 and kept his Buy rating following yesterday's "encouraging" ASCO presentation by Amgen (AMGN) regarding its KRAS G12C inhibitor AMG 510. The analyst notes that the side effect profile and response to the treatment's lowest dose in AMG 510 are positive for Mirati's MRTX849, raising his probability Adjusted Peak Sales for the latter to $1.65B from $1.33B with probability of success little changed at 52%.
06/05/19
LEHM
06/05/19
NO CHANGE
Target $123
LEHM
Overweight
Mirati Therapeutics price target raised to $123 from $85 at Barclays
Barclays analyst Gena Wang raised her price target for Mirati Therapeutics (MRTX) to $123 from $85 saying Amgen's (AMGN) AMG510 data support KRAS G12C as a validated target, and the "impressive" data provide proof of concept for potentially single agent activity in non-small cell lung cancer. The analyst continues to believe that Mirati's MRTX849 could have a more favorable profile based on the preclinical results, including "longer half-life and good tissue penetration." She reiterates an Overweight rating on Mirati Therapeutics.
06/05/19
HCWC
06/05/19
NO CHANGE
Target $117
HCWC
Buy
Mirati Therapeutics price target raised to $117 from $84 at H.C. Wainwright
H.C. Wainwright analyst Edward White raised his price target for Mirati Therapeutics (MRTX) to $117 from $84 saying the positive data for Amgen's (AMGN) AMG 510 bode well for Mirati's MRTX849. The analyst believes the AMG 510 data "somewhat derisks" the development of MRTX849/ He raised his estimate for probability of success for MRTX849 to 20% from 10% and keeps a Buy rating on Mirati Therapeutics.
06/07/19
GUGG
06/07/19
DOWNGRADE
GUGG
Neutral
Guggenheim downgrades Mirati to Neutral following near-tripling of stock
As previously reported, Guggenheim analyst Michael Schmidt downgraded Mirati Therapeutics (MRTX) to Neutral from Buy, noting that the shares have nearly tripled since data were presented at the European Society for Medical Oncology, or ESMO, meeting in October. While Schmidt said Amgen's (AMGN) KRAS inhibitor Phase I data presented at the American Society of Clinical Oncology meeting validates MRTX849's potential mechanism of action, he sees a "lot of upside" priced in at the current valuation despite the remaining development risks. He also believes investor expectations have significantly increased ahead of Mirati's own Phase I data presentation in the second half of the year.

TODAY'S FREE FLY STORIES

CHS

Chico's

$3.19

0.09 (2.90%)

15:31
06/19/19
06/19
15:31
06/19/19
15:31
Hot Stocks
Chico's says will review $3 per share revised proposal from Sycamore Partners »

Chico's FAS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTG

Pure Storage

$16.20

0.08 (0.50%)

15:29
06/19/19
06/19
15:29
06/19/19
15:29
Conference/Events
Pure Storage management to meet with KeyBanc »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

  • 09

    Jul

MGA

Magna

$47.61

0.59 (1.25%)

15:29
06/19/19
06/19
15:29
06/19/19
15:29
Upgrade
Magna rating change  »

Magna upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSTO

Vista Outdoor

$8.12

0.025 (0.31%)

15:28
06/19/19
06/19
15:28
06/19/19
15:28
Conference/Events
Vista Outdoor management to meet with KeyBanc »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

CYTX

Cytori Therapeutics

$0.25

-0.0129 (-4.83%)

15:25
06/19/19
06/19
15:25
06/19/19
15:25
Conference/Events
Cytori Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 27

    Jun

15:20
06/19/19
06/19
15:20
06/19/19
15:20
General news
More Powell: there was talk about raising the inflation goal to 4% »

More Powell: there was…

SCS

Steelcase

$17.74

0.18 (1.03%)

15:19
06/19/19
06/19
15:19
06/19/19
15:19
Options
Steelcase options imply 11.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 24

    Jun

  • 26

    Jun

  • 10

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
06/19/19
06/19
15:17
06/19/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
06/19/19
06/19
15:16
06/19/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$292.86

0.53 (0.18%)

, SPX

S&P 500

$0.00

(0.00%)

15:14
06/19/19
06/19
15:14
06/19/19
15:14
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Powell says FOMC…

SPY

SPDR S&P 500 ETF Trust

$292.86

0.53 (0.18%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$292.81

0.48 (0.16%)

, SPX

S&P 500

$0.00

(0.00%)

15:13
06/19/19
06/19
15:13
06/19/19
15:13
General news
Powell says labor market 'in a good place' »

Fed Chair Powell said…

SPY

SPDR S&P 500 ETF Trust

$292.81

0.48 (0.16%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:10
06/19/19
06/19
15:10
06/19/19
15:10
General news
Powell: there was not much support for cutting rates now »

Powell: there was not…

FB

Facebook

$185.40

-3.06 (-1.62%)

, SPY

SPDR S&P 500 ETF Trust

$292.52

0.19 (0.06%)

15:04
06/19/19
06/19
15:04
06/19/19
15:04
General news
Powell says 'a long way' from digital currencies replacing traditional currency »

Facebook (FB) has…

FB

Facebook

$185.40

-3.06 (-1.62%)

SPY

SPDR S&P 500 ETF Trust

$292.52

0.19 (0.06%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 10

    Jul

AOBC

American Outdoor Brands

$9.05

0.01 (0.11%)

15:04
06/19/19
06/19
15:04
06/19/19
15:04
Options
American Outdoor Brands options imply 17.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

SPY

SPDR S&P 500 ETF Trust

$292.70

0.37 (0.13%)

, SPX

S&P 500

$0.00

(0.00%)

14:59
06/19/19
06/19
14:59
06/19/19
14:59
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Powell says 'we have…

SPY

SPDR S&P 500 ETF Trust

$292.70

0.37 (0.13%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$197.66

-0.86 (-0.43%)

, GS

Goldman Sachs

$195.44

0.455 (0.23%)

14:58
06/19/19
06/19
14:58
06/19/19
14:58
Periodicals
Apple expanding credit card test to thousands of retail workers, Bloomberg says »

Apple (AAPL) is ramping…

AAPL

Apple

$197.66

-0.86 (-0.43%)

GS

Goldman Sachs

$195.44

0.455 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 09

    Jul

  • 16

    Jul

RRGB

Red Robin

$31.03

-0.96 (-3.00%)

14:55
06/19/19
06/19
14:55
06/19/19
14:55
Hot Stocks
Red Robin says will review Vintage Capital request for special meeting »

In a filing, Red Robin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:55
06/19/19
06/19
14:55
06/19/19
14:55
General news
Powell: "i'm sure things will change before the next meeting," »

Powell: "i'm…

SPY

SPDR S&P 500 ETF Trust

$292.78

0.45 (0.15%)

, SPX

S&P 500

$0.00

(0.00%)

14:54
06/19/19
06/19
14:54
06/19/19
14:54
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Powell says 'not…

SPY

SPDR S&P 500 ETF Trust

$292.78

0.45 (0.15%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$250.98

5.33 (2.17%)

, DVA

DaVita

$51.30

1.54 (3.09%)

14:52
06/19/19
06/19
14:52
06/19/19
14:52
Periodicals
FTC approves UnitedHealth acquisition of Davita Medical, Forbes says »

The Federal Trade…

UNH

UnitedHealth

$250.98

5.33 (2.17%)

DVA

DaVita

$51.30

1.54 (3.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

RRGB

Red Robin

$31.09

-0.9 (-2.81%)

14:52
06/19/19
06/19
14:52
06/19/19
14:52
Hot Stocks
Red Robin shareholder calls for board shakeup »

Vintage Capital, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$293.09

0.76 (0.26%)

, SPX

S&P 500

$0.00

(0.00%)

14:51
06/19/19
06/19
14:51
06/19/19
14:51
General news
Powell says no talks yet on whether next cut would be 25 or 50 basis points »

Fed chair Powell said the…

SPY

SPDR S&P 500 ETF Trust

$293.09

0.76 (0.26%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$52.68

-0.2 (-0.38%)

14:49
06/19/19
06/19
14:49
06/19/19
14:49
Options
Oracle options imply 7.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

RF

Regions Financial

$14.60

-0.27 (-1.82%)

14:45
06/19/19
06/19
14:45
06/19/19
14:45
Options
Regions Financial call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

14:45
06/19/19
06/19
14:45
06/19/19
14:45
General news
Fed Chair Powell opened his presser noting "significant changes" »

Fed Chair Powell opened…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.